芪苈强心胶囊治疗慢性心衰心室机械运动失同步的临床观察

《芪苈强心胶囊治疗慢性心衰心室机械运动失同步的临床观察》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、河南中医学院２０１２届硕士研究生学位论文芪苈强心胶囊治疗慢性心衰心室机械运动失同步的临床观察研究生姓名：张正勋导师：刘新灿教授指导组成员：王永霞教授韩景辉博士李明博士学科、专业：中西医结合临床所属院、系：第一临床医学院中国﹒郑州２０１２年４月３０日硕士学位论文原创性声明本人所呈交的硕士学位论文，是在导师刘新灿教授的指导下，独立进行科学研究工作所取得的成果。除文中已特别加以注明引用的内容外，论文中不包含任何其他个人或集体已经发表或撰写过的研究成果。对本文的研究做出重要贡献的个人和集体，均已在文中以明确方式标明并致谢。本人完全意识到本声明的法律结果由本人承担。特此声明。论文作者（签名）：年月

2、日硕士学位论文使用授权声明本人已完全了解河南中医学院有关保留、使用硕士学位论文的相关规定，同意学校保留或向国家有关部门、机构送交本学位论文的复印件和电子版，允许论文被查阅或借阅。本人授权河南中医学院可以将本论文的全部或部分内容编入有关数据库进行检索，可以采用影印、缩印或其他复制手段保存、汇编本论文（注：保密论文在解密后适用本授权声明）。特此声明。论文作者（签名）：导师（签名）：年月日年月日目录摘要·································································································

3、····1前言·····································································································4对象与方法·······························································································51临床资料··················································································

4、··········92诊断标准····························································································93病例选择标准·····················································································104分组、用药及疗程···············································································115观察指

5、标···························································································116临床疗效判断标准···············································································127统计学分析························································································12结果···············

6、······················································································9讨论····································································································131现代医学对慢性心衰心室机械运动失同步的研究······································132祖国医学对慢性心衰的认识·······························

7、···································143导师学术观点····················································································164芪苈强心胶囊的方解及药理研究····························································175疗效评价特点····